Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06922097

Treating Intraoperative Bradycardia in Non-cardiac Surgery Patients With Atropine at Heart Rates Below 60 Versus 30 Beats Per Minute and Norepinephrine Requirements

Treating Intraoperative Bradycardia in Non-cardiac Surgery Patients With Atropine at Heart Rates Below 60 Versus 30 Beats Per Minute and Norepinephrine Requirements: the Randomized RAPID Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
186 (estimated)
Sponsor
University of Hamburg-Eppendorf · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The RAPID trial is a randomized, single-center trial investigating whether giving atropine at heart rates below 60 beats per minute versus giving atropine only at heart rates below 30 beats per minute reduces the amount of norepinephrine needed to keep MAP above 65 mmHg in non-cardiac surgery patients with intraoperative bradycardia.

Conditions

Interventions

TypeNameDescription
DRUGGiving atropine at heart rates below 60 beats per minuteIn patients assigned to the atropine therapy at heart rates below 60 beats per minute, atropine will be given at a dose of 0.5 mg when heart rate is below 60 beats per minute for one continuous minute. A second and third atropine dose of 0.5 mg will be given if heart rate remains or again drops below 60 beats per minute for one continuous minute. Patients will not be given more than 1.5 mg atropine.
DRUGGiving atropine at heart rates below 30 beats per minuteIn patients assigned to atropine therapy at heart rates below 30 beats per minute, atropine will be given at a dose of 0.5 mg when heart rate is below 30 beats per minute for one continuous minute. A second and third atropine dose of 0.5 mg will be given if heart rate remains or again drops below 30 beats per minute for one continuous minute. Patients will not be given more than 1.5 mg atropine.

Timeline

Start date
2025-04-07
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2025-04-10
Last updated
2025-05-20

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06922097. Inclusion in this directory is not an endorsement.